| Structure |
Chemical Name |
CAS |
MF |
 |
(-)-Dibenzoyl-L-tartaric acid monohydrate |
62708-56-9 |
C18H16O9 |
 |
Dibenzoyl-L-tartaric acid |
2743-38-6 |
C18H14O8 |
 |
(R)-(+)-1-(4-Methylphenyl)ethylamine |
4187-38-6 |
C9H13N |
 |
(R)-3-hydroxypentanoic acid |
53538-53-7 |
C5H10O3 |
 |
(5S)-5-methylmorpholin-3-one |
119844-66-5 |
C5H9NO2 |
 |
Ethyl (R)-3-hydroxybutyrate |
24915-95-5 |
C6H12O3 |
 |
(S)-5-AMINO-PIPERIDIN-2-ONE HCL |
672883-95-3 |
C5H11ClN2O |
 |
cis-4-Hydroxycyclohexanecarboxylic acid |
3685-22-1 |
C7H12O3 |
 |
(R)-4-(1-Aminoethyl)phenol (S)-hydroxybutanedioate salt |
134855-89-3 |
C8H12BrNO |
 |
cis-2,6-Dimethyl-4-oxo-piperidine-1-carboxylic acid tert-butyl ester |
1005397-64-7 |
C12H21NO3 |
 |
(R)-3-Hydroxy Myristic Acid |
28715-21-1 |
C14H28O3 |
 |
(DHQ)2PHAL |
140924-50-1 |
C48H54N6O4 |
 |
cis-3-Hydroxycyclobutanecarboxylic acid |
552849-33-9 |
C5H8O3 |
 |
(S)-Pro-xylane |
868156-46-1 |
C8H16O5 |
 |
(R)-3-Hydroxybutyric acid |
625-72-9 |
C4H8O3 |
![2,2',3,3'-Tetrahydro-1,1'-spirobi[1H-indene]-7,7'-diol](/CAS2/GIF/223137-87-9.gif) |
2,2',3,3'-Tetrahydro-1,1'-spirobi[1H-indene]-7,7'-diol |
223137-87-9 |
C17H16O2 |
 |
1,1'-SPIROBIINDANE-7,7'-DIOL |
223259-63-0 |
C17H16O2 |
![(R)-2,2',3,3'-TETRAHYDRO-1,1'-SPIROBI[INDENE]-7,7'-DIOL, >=95%](/CAS/20150408/GIF/223259-62-9.gif) |
(R)-2,2',3,3'-TETRAHYDRO-1,1'-SPIROBI[INDENE]-7,7'-DIOL, >=95% |
223259-62-9 |
C17H16O2 |
![(11aR)-5-hydroxy-10,11,12,13-tetrahydro-5-oxide-Diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin](/CAS/20150408/GIF/1352810-35-5.gif) |
(11aR)-5-hydroxy-10,11,12,13-tetrahydro-5-oxide-Diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin |
1352810-35-5 |
C17H15O4P |
![(11aS)-5-hydroxy-10,11,12,13-tetrahydro-5-oxide-Diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin](/CAS/20150408/GIF/1258327-03-5.gif) |
(11aS)-5-hydroxy-10,11,12,13-tetrahydro-5-oxide-Diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin |
1258327-03-5 |
C17H15O4P |